Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (851-860 of 4,265) with videos related to

Pageof 427
Sort By:
Cancer Discovery|August 30, 2012
Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylationStefan T Börno, Axel Fischer, Martin Kerick, et al.
Cancer Discovery|July 4, 2012
DDX5 regulates DNA replication and is required for cell proliferation in a subset of breast cancer cellsAnthony Mazurek, Weijun Luo, Alexander Krasnitz, et al.
Cancer Discovery|August 29, 2012
Investigating metformin for cancer prevention and treatment: the end of the beginningMichael N Pollak
Cancer Discovery|August 14, 2012
RAF/MEK dependence of KRAS-mutant pancreatic ductal adenocarcinomasAphrothiti J Hanrahan, David B Solit
Cancer Discovery|August 14, 2012
STATe-of-the-art approach: using oligonucleotide decoys to target the "undruggable"Priya Koppikar, Jacqueline Bromberg
Cancer Discovery|July 11, 2012
VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancerHira Lal Goel, Cheng Chang, Bryan Pursell, et al.
Cancer Discovery|July 17, 2012
BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitorsKimberly Brown Dahlman, Junfeng Xia, Katherine Hutchinson, et al.
Cancer Discovery|July 13, 2012
Bugging tumorsRobert M Hoffman
Cancer Discovery|July 6, 2012
Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signalingHua-Jung Li, Ferenc Reinhardt, Harvey R Herschman, et al.
Cancer Discovery|February 4, 2015
Therapeutic insights from genomic studies of head and neck squamous cell carcinomasPeter S Hammerman, D Neil Hayes, Jennifer R Grandis
Pageof 427

Showing results (851-860 of 4,265) with videos related to

Sort By:
Pageof 427
Cancer Discovery|August 30, 2012
Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylationStefan T Börno, Axel Fischer, Martin Kerick, et al.
Cancer Discovery|July 4, 2012
DDX5 regulates DNA replication and is required for cell proliferation in a subset of breast cancer cellsAnthony Mazurek, Weijun Luo, Alexander Krasnitz, et al.
Cancer Discovery|August 29, 2012
Investigating metformin for cancer prevention and treatment: the end of the beginningMichael N Pollak
Cancer Discovery|August 14, 2012
RAF/MEK dependence of KRAS-mutant pancreatic ductal adenocarcinomasAphrothiti J Hanrahan, David B Solit
Cancer Discovery|August 14, 2012
STATe-of-the-art approach: using oligonucleotide decoys to target the "undruggable"Priya Koppikar, Jacqueline Bromberg
Cancer Discovery|July 11, 2012
VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancerHira Lal Goel, Cheng Chang, Bryan Pursell, et al.
Cancer Discovery|July 17, 2012
BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitorsKimberly Brown Dahlman, Junfeng Xia, Katherine Hutchinson, et al.
Cancer Discovery|July 13, 2012
Bugging tumorsRobert M Hoffman
Cancer Discovery|July 6, 2012
Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signalingHua-Jung Li, Ferenc Reinhardt, Harvey R Herschman, et al.
Cancer Discovery|February 4, 2015
Therapeutic insights from genomic studies of head and neck squamous cell carcinomasPeter S Hammerman, D Neil Hayes, Jennifer R Grandis
Pageof 427